ZA855017B - Solid medicament formulations containing dihydropyridines and a process for their preparation - Google Patents

Solid medicament formulations containing dihydropyridines and a process for their preparation

Info

Publication number
ZA855017B
ZA855017B ZA855017A ZA855017A ZA855017B ZA 855017 B ZA855017 B ZA 855017B ZA 855017 A ZA855017 A ZA 855017A ZA 855017 A ZA855017 A ZA 855017A ZA 855017 B ZA855017 B ZA 855017B
Authority
ZA
South Africa
Prior art keywords
preparation
formulations containing
solid medicament
medicament formulations
dihydropyridines
Prior art date
Application number
ZA855017A
Inventor
Wolfgang Schmidt
Helmut Luchtenberg
Eduard Porges
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6239792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA855017(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA855017B publication Critical patent/ZA855017B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Abstract

The preparations are rapidly absorbable and contain dihydropyridines, polyvinylpyrrolidone and crosslinked polyvinylpyrrolidone.
ZA855017A 1984-07-04 1985-07-03 Solid medicament formulations containing dihydropyridines and a process for their preparation ZA855017B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843424553 DE3424553A1 (en) 1984-07-04 1984-07-04 SOLID DRUG PREPARATIONS WITH DIHYDROPYRIDINE AND METHOD FOR THE PRODUCTION THEREOF

Publications (1)

Publication Number Publication Date
ZA855017B true ZA855017B (en) 1986-02-26

Family

ID=6239792

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA855017A ZA855017B (en) 1984-07-04 1985-07-03 Solid medicament formulations containing dihydropyridines and a process for their preparation

Country Status (15)

Country Link
EP (1) EP0167909B2 (en)
JP (1) JPH0665644B2 (en)
KR (1) KR920006908B1 (en)
AT (1) ATE71297T1 (en)
AU (1) AU570328B2 (en)
CA (1) CA1255597A (en)
DE (2) DE3424553A1 (en)
DK (1) DK304485A (en)
ES (1) ES8607018A1 (en)
FI (1) FI852610L (en)
GR (1) GR851617B (en)
HU (1) HU197844B (en)
IL (1) IL75686A (en)
PT (1) PT80752B (en)
ZA (1) ZA855017B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
US5015479A (en) * 1987-02-02 1991-05-14 Seamus Mulligan Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine
US5001139A (en) * 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
DE4130173A1 (en) * 1991-09-11 1993-03-18 Bayer Ag PHARMACEUTICAL PREPARATIONS WITH A SPECIAL CRYSTAL MODIFICATION OF 1,4-DIHYDRO-2,6-DIMETHYL-4- (3-NITROPHENYL) -3,5-PYRIDINDICARBONIC ACID ISOPROPYL- (2-METHOXYETHYL) ESTER
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
CN1082811C (en) * 1995-03-29 2002-04-17 盐野义制药株式会社 Gelatin capsule with adjusted water activity
CO4771151A1 (en) * 1996-01-19 1999-04-30 Rachitzky Falicman Pablo Alberto PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION CONTAINING NIFEDIPINE AND THE PHARMACEUTICAL PREPARATION OBTAINED THROUGH THE SAME
AU2256702A (en) 2000-12-01 2002-06-11 Kyowa Hakko Kogyo Kk Composition improved in solubility or oral absorbability
DE10117049A1 (en) * 2001-04-05 2002-10-17 Novartis Ag New pharmaceutical composition useful for preparing solid and liquid dosage forms, e.g. ophthalmic solutions, comprises an anionic surfactant with a basic polymer or a cationic surfactant with acidic polymer, and an active ingredient
JP5072748B2 (en) * 2007-07-10 2012-11-14 株式会社 メドレックス Amlodipine stable solution and jelly
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0078430B2 (en) * 1981-10-29 1993-02-10 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
DE3142853A1 (en) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Solid pharmaceutical compositions containing nifedipine and process for their production
DE3318649A1 (en) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen TWO-PHASE FORMULATION
JPS6038322A (en) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd Easily soluble solid preparation containing dihydropyridine-a substance
EP0143857B1 (en) * 1983-11-30 1988-04-06 Siegfried Aktiengesellschaft Therapeutic coronary composition in the form of soft gelatine capsules
DE3427402A1 (en) * 1984-07-25 1986-01-30 Bayer Ag, 5090 Leverkusen NEW COMBINATION DEVICE, METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS A MEDICINAL PRODUCT

Also Published As

Publication number Publication date
DK304485A (en) 1986-01-05
EP0167909B1 (en) 1992-01-08
HU197844B (en) 1989-06-28
EP0167909B2 (en) 1994-10-19
FI852610L (en) 1986-01-05
IL75686A0 (en) 1985-11-29
CA1255597A (en) 1989-06-13
ES8607018A1 (en) 1986-06-16
AU4429885A (en) 1986-01-09
ES544787A0 (en) 1986-06-16
PT80752B (en) 1987-10-20
EP0167909A2 (en) 1986-01-15
AU570328B2 (en) 1988-03-10
FI852610A0 (en) 1985-07-02
JPS6118725A (en) 1986-01-27
GR851617B (en) 1985-11-26
EP0167909A3 (en) 1987-10-14
KR920006908B1 (en) 1992-08-22
PT80752A (en) 1985-08-01
DK304485D0 (en) 1985-07-03
ATE71297T1 (en) 1992-01-15
HUT41259A (en) 1987-04-28
DE3424553A1 (en) 1986-01-09
IL75686A (en) 1988-11-30
DE3585107D1 (en) 1992-02-20
JPH0665644B2 (en) 1994-08-24
KR860000864A (en) 1986-02-20

Similar Documents

Publication Publication Date Title
AU558331B2 (en) Solid medicament formulations containing nifedipine, and processes for their preparation
IL91404A0 (en) Substituted 4-azatricyclo(22.3.1.0 4,9)octacos-18-ene derivations,their preparation and pharmaceutical compositions containing them
ZA83726B (en) Fibrinogen formulations,a process for its preparation and its use
EP0412350A3 (en) Renininhibitors, procedure for their preparation and use as medicaments
JPS6413076A (en) Novel compound, manufacture and medicinal composition
ZA855017B (en) Solid medicament formulations containing dihydropyridines and a process for their preparation
JPS6413088A (en) Novel compound, manufacture and medicinal composition
AU1665088A (en) New compounds, processes for their preparation and uses thereof
PH24599A (en) Amonoycyllabdanes, pharmaceutical compositions and a process for the preparations thereof
AR243180A1 (en) Substituted 3,4-dihydro-2h-benzopyranes, process for their preparation, their use and pharmaceutical preparations based on these compounds
LTIP1687A (en) Novel antiarrhythmic agents, process for the preparation thereof and pharmaceutical compositions
AU2197688A (en) New compounds, processes for their preparation and use thereof
IL87038A0 (en) Substituted benzimidazoles,a process for the preparation thereof and pharmaceutical formulations containing them
AU1630188A (en) Substituted compounds, processes for their preparation and their use as medicaments
AU575488B2 (en) Benzoylurea derivatives, process for their preparation, and insecticides
EP0246861A3 (en) Pharmaceutical composition based on crotoxine, process for preparing the active component and the pharmaceutical composition
ZA854330B (en) Insulin formulations,processes for their preparation and their use
YU12189A (en) Derivatives tetrahydropyridin
IL85162A0 (en) 3-methylenespiro(benzofuranpiperidines),a process for the preparation thereof,and pharmaceutical compositions containing them
AU637400B2 (en) Substituted vinylcephalosporins, processes for their preparation and their use as medicaments
ZA831491B (en) Solid,rapidly released medicament preparations containing dihydropyridines,and processes for their preparation
ZA883718B (en) Substituted vinylcephalosporins,processes for their preparation and their use as medicaments
ZA883720B (en) Substituted vinylcephalosporins,processes for their preparation and their use as medicaments
PH24835A (en) Solid,rapidly released medicament preparations containing dihydropyridines,and process for their preparation
IL68080A0 (en) Solid,rapidly absorbable medicament preparations containing dihydropyridines and their preparation